20/20 Onsite Tops 20+ CNS Trials, Driving Quality Ocular Endpoint Protection at Scale

BOSTON--(BUSINESS WIRE)-- #ClinicalTrials--20/20 Onsite tops 20 CNS trials, delivering quality ocular endpoint protection via point-of-need mobile vision clinics. 95+ NPS & 100% timelines met.